Global Access Health (GAH), a social enterprise dedicated to providing affordable medical products for global health, today formally introduced its first portfolio company, Global Access Diagnostics (GADx). GADx has been created to address gaps in the global provision of diagnostics with a focus on expanding affordable access to quality tests. The Company combines expertise in rapid diagnostics development from Mologic Ltd with low-cost manufacturing and scale-up capability of sister company, Global Access Diagnostics (GAD)...

An excellent mood in five halls, delighted faces and many lively discussions at the exhibition booths: At analytica 2022, the international laboratory industry met again in person from June 21 to 24 in Munich. At the world’s leading trade fair, 891 exhibitors presented their innovations for the entire range of laboratory and analytics technology, life sciences and biotechnology to around 26,000 visitors...

The world's first electron diffractometer offers measurement results of unprecedented quality for the pharmaceutical, electromobility and new materials sectors. The Experience Center for Electron Diffraction has now started operations in Basel-Allschwil. The Swiss company ELDICO Scientific operates the world's first electron diffractometer there...

The autoclaves from Systec GmbH can be used for all laboratory applications: for sterilizing solids, liquids, waste, and biological hazardous substances. All autoclaves can be equipped with options to optimize the sterilization process. The options required for the corresponding sterilization processes can be added to your configuration. When sterilizing solids and waste in bags, for example, Systec autoclaves can be equipped with a vacuum system that completely removes the air from the product...

Evident, a wholly owned subsidiary of Olympus Corporation, is proud to announce that its Olympus Provi™ CM20 incubation monitoring system is the 2022 recipient of the prestigious "Best of the Best" award in the Product Design category of the Red Dot Design Award. This Award is bestowed on a product that the Red Dot Jury deems as groundbreaking and is the highest honor given in this world-renowned design competition...

At the fair, MolGen presents the PurePrep 24, an DNA/RNA extraction system for high sample volume applications, such as isolating DNA from blood samples. The PurePrep 4800 is a complete DNA/RNA extraction system with sample barcode scanning, liquid handling for reagents and samples, extraction and PCR setup in one system. The newest MolGen testing device is MoaA RT. This multiplex viruses RT-qPCR kit is a single well, which targets 5 highly infectious diseases..

DataApex is pleased to announce that a new control module for the Nexera LC-40 HPLC system has been released! It is a part of Clarity - Shimadzu Edition Chromatography Software that is dedicated to the European market. Customers can use a control module for the Nexera LC-40 HPLC system in combination with hundreds of instruments supported in Clarity, including the Shimadzu Nexis GC-2030....

Merck, a leading science and technology company, has signed an agreement with the Administrative Management Committee of Wuxi National High-Tech Industrial Development Zone to significantly expand Merck’s first Asia-Pacific Mobius® Single-Use manufacturing center in China. For more than two decades, Merck’s Life Science business sector...

A partnership between antibody development experts and global healthcare providers creates a new COVID-19 treatment for immunocompromised, high-risk, and vaccine refractory individuals, effective against major variants including Omicron. ProteoGenix(market-leading antibody provider), Aseem Healthcare (global healthcare company), and Trident Biopharm Solutions (life science consultancy agency)...

Biosynth Carbosynth (“Biosynth”), a supplier of critical materials to the life science industry, announces the acquisition of Aalto Bio Reagents (“Aalto”), a leading developer and provider of biological materials to the in-vitro diagnostic (IVD) and vaccine development industry in the field of emerging disease. The acquisition represents a further milestone in Biosynth’s development, which broadens its capabilities and offering to the IVD industry...

The Rutherford Health group (the Group) which operates a network of cancer and diagnostic centres in the UK, announce that an application is to be made to place the Group into liquidation. Since 2015, Rutherford Health has built a network of oncology centres known as the Rutherford Cancer Centres which are located in South Wales, Northumberland, Liverpool and Thames Valley....

Aptamer Group plc, the developer of novel Optimer® binders to enable innovation in the life sciences industry, is pleased to announce that it has extended its collaboration agreement with PinotBio (Gyeonggi-do, Korea), a clinical-stage oncology-focused biotechnology company, to develop four new Optimer-drug conjugates for use as precision chemotherapeutics. The partnership was first initiated in June 2021 targeting haematological cancers...

Indica Labs, the leading provider of computational pathology software and services, is excited to announce a CE-IVD Mark for HALO Prostate AI, a deep learning-based screening tool designed to assist pathologists in identifying and grading prostate cancer in core needle biopsies. Prostate cancer is the most common cancer diagnosed in men. With over 1.4 million cases reported worldwide in 2020, the incidence rates continue to rise with wider availability of screening tests, such as PSA....

Illumina, Inc., a global leader in DNA sequencing and array-based technologies, and Deerfield Management, a healthcare investment management firm, today announced a five-year partnership to apply a genetic-led approach to the discovery and development of novel therapies for diseases with unmet medical needs. The partnership aims to leverage genomic tools and genetic knowledge to select programs with a higher probability of success in order to lower research and development costs...

Alamar Biosciences (Alamar), a platform company focused on transforming the field of proteomics to enable the early detection of cancer and other diseases, and Mologic, Ltd. (Mologic), part of the recently formed social enterprise Global Access Health and a leading developer of lateral flow and rapid diagnostic tests (RDTs), has announced a collaboration to utilize Alamar’s novel antibodies against SARS-CoV-2 Nucleocapsid (N) protein for Mologic’s future COVID-19 RDTs.

Scientific Laboratory Supplies (SLS) – the leading supplier of equipment, chemicals and consumables for laboratory use in the UK – has announced the acquisition of two businesses, Gem Scientific and Northern Balance, to expand its product and service offerings. Both companies will continue to operate as independent entities and retain all employees, whilst harnessing SLS’s business support and infrastructure to benefit all parties, stakeholders and customers.  ...

Thermo Fisher Scientific Inc., the world leader in serving science, and TransMIT GmbH Center for Mass Spectrometric Developments have announced a co-marketing agreement to promote the use of a mass spectrometry imaging (MSI) platform for spatial multi-omics applications in pharma and clinical labs. As part of the relationship, TransMIT will combine its proprietary scanning microprobe matrix-assisted laser desorption/ionization (SMALDI) MSI and 3D-surface MSI technology...

Dotmatics, a leader in R&D scientific software connecting science, data, and decision-making, has announced it has been selected by Umicore Corporate Research and Development, which is part of global materials technology and recycling company Umicore, as informatics partner for its Corporate R&D (CRD) digitalization project. The strategic agreement to implement core elements of Dotmatics’ R&D innovation platform within CRD, including electronic laboratory notebook...

Merck, a leading science and technology company, is expanding its membrane and filtration manufacturing capabilities in Ireland. The company will invest approximately €440 million to increase membrane manufacturing capacity in Carrigtwohill and to build a new manufacturing facility at Blarney Business Park, both in Cork, Ireland. The investment, which is the largest in a single site ever for Merck’s Life Science business sector, will create more than 370 permanent jobs by the end of 2027...